As RNA-based therapeutics grow in popularity, ethical considerations become increasingly important. South American healthcare systems must balance innovation with responsible implementation.

One key concern is equitable access. Advanced RNA therapies could become expensive, raising questions about fairness across regions with differing income levels. Policymakers must consider how to avoid widening health gaps.

Informed consent is also crucial. Because RNA technologies are scientifically complex, clear communication is essential to ensure patients understand benefits, risks, and unknowns.

Another consideration involves data privacy. Genetic and RNA sequencing data must be stored and used responsibly.

By addressing these ethical challenges proactively, South America can adopt RNA technologies safely and inclusively.